Loading view.
Satellite CME Symposium
A Bold Frontier: Shattering the Limits of Conventional Therapies and Reshaping the Future of Lung Cancer Treatment with TROP2-Targeting ADCs and Rational Combinations
Hall 405A
Sponsored by PVI, PeerView Institute for Medical Education
Supported by an educational grant from Gilead
Featured Satellite CME Symposium
Unlocking the Power of Genomic Testing in NSCLC: Implementing Personalized Therapy to Impact Outcomes
Hall 406
Sponsored by Medscape Oncology
Supported by an educational grant from Lilly
Satellite CME Symposium
Treatment Approaches in EGFR-Mutant NSCLC Post-TKI and Chemotherapy: What Now and What Next?
Hall 406
Sponsored by PeerVoice
Supported by an educational grant from Daiichi Sankyo, Inc.
Featured Satellite CME Symposium
MET Inhibition in Metastatic NSCLC “In the Spotlight”
Hall 406
Sponsored by Agile
Supported by an educational grant from Merck KGaA
Satellite CME Symposium
Applying Multidisciplinary Expertise and Heterogeneous Skills in Clinical Practice: Transforming Non-small Cell Lung Cancer Treatment with Immunotherapy
Hall 405C
Sponsored by Med Learning Group
Supported by an educational grant from Regeneron Pharmaceuticals
Satellite CME Symposium
Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens
Hall 406
Sponsored by PeerView Institute for Medical Education
Supported by an educational grant from Daiichi Sankyo, Inc.